Hims & Hers Health Inc Ordinary Shares - Class A (HIMS)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$26.48

Buy

$26.50

arrow-up$0.16 (+0.61%)

Prices updated at 30 Apr 2026, 16:19 EDT

Prices minimum 15 mins delay

Prices in USD

S&P 500

0.38%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Andrew Dudum

CEO

Mr. Andrew Dudum

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

2,442

Head office

2269 Chestnut Street

San Francisco

United States

94123

+1 415 851-0195

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Kare Schultz Independent Director	0.04m
Mr. David Bolling Wells Lead Independent Director	0.09m
Mr. Christopher D. Payne Independent Director	0.06m
Ms. Anja L. Manuel Independent Director	0.05m
Mr. Kofi Amoo-Gottfried Independent Director	-
Mr. Andrew Dudum Chief Executive Officer and Chairman of the Board	0.49m
Dr. Patrick H. Carroll, M.D. Director and Global Chief Medical Officer	0.04m
Ms. Soleil Boughton Chief Legal Officer and Corporate Secretary	0.46m
Dr. Delos M. Cosgrove, M.D. Independent Director	0.04m
Ms. Andrea G. Perez Garcia Independent Director	0.06m
Ms. Irene Becklund Senior Vice President, Controller and Chief Accounting Officer	-
Ms. Deborah M. Autor Chief Policy Officer and Director	0.04m
Mr. Oluyemi Okupe Chief Financial Officer	0.53m
Ms. Christiane Pendarvis Independent Director	0.05m
Mr. Michael Chi Chief Operating Officer	0.49m
Mr. Mohamed Elshenawy Chief Technology Officer	0.38m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	26,573,504
Vanguard Group Inc	20,925,666
JPMorgan Chase & Co	18,838,270
BlackRock Fund Advisors	15,956,978
Capital World Investors	14,322,912

Director dealings

Date chevron-l-regular chevron-r-regular	Action
22 Dec 2025	-
17 Dec 2025	-
17 Dec 2025	-
17 Dec 2025	-
17 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.